Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CPRX
#1657
Catalyst Pharmaceutical Inc.
25.850
0
USD
-1.30%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-1.30%
Changement Mensuel
+10.66%
Evolution sur 6 mois
+21.88%
Changement Annuel
+21.88%
Clôture Précédente
26.190
0
Open
25.850
0
Bid
Ask
Low
25.850
0
High
25.850
0
Volume
94
Marchés
Actions des Marchés US
Soins de Santé
CPRX
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
121.45 M
121.98 M
122.39 M
122.91 M
122.12 M
—
Valuation ratios
Enterprise value
2.02 B
2.38 B
2 B
1.73 B
2.14 B
8.25 B
Price to earnings ratio
15.93
15.45
13.15
11.45
13.89
53.94
Price to sales ratio
5.3
5.69
4.9
4.31
5.04
19.96
Price to cash flow ratio
10.87
11.35
9.95
10.62
14.23
46.16
Price to book ratio
3.58
1.09
0.9
0.76
3.11
5.86
Enterprise value to EBITDA ratio
7.46
7.53
5.78
4.44
6.43
24.17
Profitability ratios
Return on assets %
0.07
0.06
0.05
0.05
0.05
0.21
Return on equity %
0.08
0.07
0.06
0.06
0.06
0.24
Return on invested capital %
82.27
89.47
91.41
88.29
75.45
344.62
Gross margin %
84.74
87.33
85.94
84.73
82.91
340.92
Operating margin %
44.31
44.81
45.24
44.66
40.52
175.22
EBITDA margin %
77.34
58.1
64.44
69.89
71.34
263.78
Net margin %
39.44
40.12
35.55
35.57
34.53
145.77
Liquidity ratios
Quick ratio
5.01
5.96
6.55
6.4
5.82
24.74
Current ratio
5.17
6.14
6.71
6.62
6.08
25.55
Inventory turnover
1.09
0.91
1.07
0.97
0.8
3.75
Asset turnover
0.17
0.16
0.16
0.15
0.14
0.6
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.57
0.47
0.56
0.26
0.35
1.64
EBIT per share
0.58
0.57
0.59
0.59
0.56
2.32
EBITDA per share
0.88
0.65
0.74
0.82
0.86
3.06
Total debt per share
—
—
—
—
—
—
Cash per share
4.14
4.57
5.12
5.43
5.57
20.69
Net current asset value per share
4.99
5.4
5.95
6.71
7.03
25.08
Tangible book value per share
4.57
5.1
5.63
6.23
6.46
23.42
Working capital per share
4.03
4.52
5.06
5.69
5.87
21.15
Book value per share
5.82
6.26
6.71
7.24
7.5
27.71
Nouvelles
TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication
NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up
CGON Stock Up 60.8% in Six Months: Here's What You Need to Know
Does Catalyst (CPRX) Have the Potential to Rally 28.87% as Wall Street Analysts Expect?
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now